KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Other Non-Current Assets (2016 - 2020)

Abbott Laboratories' Other Non-Current Assets history spans 12 years, with the latest figure at $824.0 million for Q4 2020.

  • For Q4 2020, Other Non-Current Assets rose 19.94% year-over-year to $824.0 million; the TTM value through Dec 2020 reached $824.0 million, up 19.94%, while the annual FY2020 figure was $824.0 million, 19.94% up from the prior year.
  • Other Non-Current Assets for Q4 2020 was $824.0 million at Abbott Laboratories, up from $687.0 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $824.0 million in Q4 2020 and bottomed at $12.0 million in Q3 2018.
  • The 5-year median for Other Non-Current Assets is $266.5 million (2016), against an average of $334.5 million.
  • The largest annual shift saw Other Non-Current Assets skyrocketed 25550.0% in 2016 before it tumbled 96.1% in 2017.
  • A 5-year view of Other Non-Current Assets shows it stood at $513.0 million in 2016, then crashed by 96.1% to $20.0 million in 2017, then soared by 2815.0% to $583.0 million in 2018, then increased by 17.84% to $687.0 million in 2019, then rose by 19.94% to $824.0 million in 2020.
  • Per Business Quant, the three most recent readings for ABT's Other Non-Current Assets are $824.0 million (Q4 2020), $687.0 million (Q4 2019), and $583.0 million (Q4 2018).